« Previous
Next »
Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3
, Pages 153-155
, May 2008
Efficiency of Citicoline in Increasing Muscular Strength of Patients with Nontraumatic Cerebral Hemorrhage: A Double-blind Randomized Clinical Trial
References
- . Citicoline inhibits MAP kinase signaling pathways after focal cerebral ischemia. Neurochem Res. 2005;30:1067–1073
- . Citicoline Ferrer Internacional. J Neurosci Res. 2002;70:133–139
- . Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: A review of the literature. Altern Med Rev. 2004;9:17–31
- . CDP-choline. Pharmacol Clin Rev. 1995;17:1–54(suppl)
- Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging: Citicoline 010 investigators. Ann Neurol. 2000;48:713–722
- Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. 1999;30:427–431discussion 431–432
- Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke. 1998;29:2136–2140
- Trial Investigators. Citicoline in intracerebral hemorrhage: A double-blind, randomized, placebo-controlled, multi-center pilot study. Cerebrovasc Dis. 2006;21:380–385
- . Bates' guide to physical examination and history taking. 9th ed.. Philadelphia: Lippincott Williams and Wilkins; 2007;
- Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850–2857
- Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience. 2003;118:107–113
- Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci. 2006;247:119–120
- Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000mg citicoline in acute ischemic stroke patients. Neurology. 2001;57:1595–1602
- A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 1999;30:2592–2597
- . Observation of therapeutic effect of Salviae miltiorrhiza and cytosine diphosphate-choline injection on patients with hypertensive cerebral hemorrhage. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000;20:94–96
- Effects of YM-14673, a new TRH analogue, on neurological deficits in rats with experimental cerebral hematoma. Arch Int Pharmacodyn Ther. 1989;299:55–64
- . Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J Neurosci Res. 2003;73:308–315
- . Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res. 2002;70:133–139
- . Membrane stabilizer: Citicoline. Curr Med Res Opin. 2002;18:s14–s17(suppl)
- . Citicoline: Neuroprotective mechanisms in cerebral ischemia. J Neurochem. 2002;80:12–23
- Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2003;5:441–449
- CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: Phosphocholine cytidylyltransferase after stroke. J Biol Chem. 2006;281:6718–6725
- . Citicoline (CDP-choline): Mechanisms of action and effects in ischemic brain injury. Neurol Res. 1995;17:281–284
PII: S1052-3057(08)00018-9
doi: 10.1016/j.jstrokecerebrovasdis.2008.01.006
© 2008 National Stroke Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3
, Pages 153-155
, May 2008
